Send the following on WhatsApp
Continue to ChatMenarini Group 和 Radius Health, Inc. 宣佈在《臨床腫瘤學期刊》公佈 elacestrant 關鍵第 3 期 EMERALD 臨床試驗數據 https://geneonline.news/menarini-group-%e5%92%8c-radius-health-inc-%e5%ae%a3%e4%bd%88%e5%9c%a8%e3%80%8a%e8%87%a8%e5%ba%8a%e8%85%ab%e7%98%a4%e5%ad%b8%e6%9c%9f%e5%88%8a%e3%80%8b%e5%85%ac%e4%bd%88-elacestrant-%e9%97%9c/